Article info

Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Authors

  1. Correspondence to Professor Irene J Higginson, Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, Kings College London, London SE5 9PJ, UK; irene.higginson{at}kcl.ac.uk
View Full Text

Citation

Higginson IJ, Wilcock A, Johnson MJ on behalf of BETTER-B Feasibility Trial Group, et al
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Publication history

  • Received July 26, 2019
  • Revised November 1, 2019
  • Accepted November 18, 2019
  • First published January 8, 2020.
Online issue publication 
January 27, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.